Search Results - Hayley S. McLoughlin

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture

    Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture by Kristen H. Schuster, Alexandra F. Putka, Hayley S. McLoughlin

    Published 2022-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Pathogenesis of SCA3 and implications for other polyglutamine diseases

    Pathogenesis of SCA3 and implications for other polyglutamine diseases by Hayley S. McLoughlin, Lauren R. Moore, Henry L. Paulson

    Published 2020-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias

    Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias by Alexandra F. Putka, Juan P. Mato, Hayley S. McLoughlin

    Published 2023-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways.

    Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways. by Li Zeng, Dapeng Zhang, Hayley S McLoughlin, Annie J Zalon, L Aravind, Henry L Paulson

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models

    Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models by Lauren R. Moore, Gautam Rajpal, Ian T. Dillingham, Maya Qutob, Kate G. Blumenstein, Danielle Gattis, Gene Hung, Holly B. Kordasiewicz, Henry L. Paulson, Hayley S. McLoughlin

    Published 2017-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3

    Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3 by David Mengel, Isabel G. Wellik, Kristen H. Schuster, Sabrina I. Jarrah, Madeleine Wacker, Naila S. Ashraf, Gülin Öz, Matthis Synofzik, Maria do Carmo Costa, Hayley S. McLoughlin

    Published 2023-09-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Regional sex differences in neurochemical profiles of healthy mice measured by magnetic resonance spectroscopy at 9.4 tesla

    Regional sex differences in neurochemical profiles of healthy mice measured by magnetic resonance spectroscopy at 9.4 tesla by Ivan Tkáč, Tiankai Xie, Nitya Shah, Sarah Larson, Janet M. Dubinsky, Rocio Gomez-Pastor, Hayley S. McLoughlin, Harry T. Orr, Lynn E. Eberly, Lynn E. Eberly, Gülin Öz

    Published 2023-10-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line

    Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line by Lauren R. Moore, Laura Keller, David D. Bushart, Rodrigo G. Delatorre, Duojia Li, Hayley S. McLoughlin, Maria do Carmo Costa, Vikram G. Shakkottai, Gary D. Smith, Henry L. Paulson

    Published 2019-08-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3

    Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3 by Kristen H. Schuster, Danielle M. DiFranco, Alexandra F. Putka, Alexandra F. Putka, Juan P. Mato, Juan P. Mato, Sabrina I. Jarrah, Nicholas R. Stec, Vikram O. Sundararajan, Hayley S. McLoughlin

    Published 2023-02-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases

    Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases by Mark L. Schultz, Maria V. Fawaz, Ruth D. Azaria, Todd C. Hollon, Elaine A. Liu, Thaddeus J. Kunkel, Troy A. Halseth, Kelsey L. Krus, Ran Ming, Emily E. Morin, Hayley S. McLoughlin, David D. Bushart, Henry L. Paulson, Vikram G. Shakkottai, Daniel A. Orringer, Anna S. Schwendeman, Andrew P. Lieberman

    Published 2019-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: